ARAlon Rainish

Alon Rainish

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alon Rainish has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Dynamics of Ligand Binding Sites and Chloride Penetration in a Bitter Taste GPCR

    by Alon Rainish, Liel Sapir, Masha Y. Niv

    Taste perception strongly influences food choice, drug compliance, and dietary behavior. Bitter taste receptors belong to a subfamily of Family A GPCRs, while having unique features and deviations from conserved motifs. Recent cryo-EM structures revealed that the human bitter taste receptor TAS2R14 contains not only the canonical extracellular binding site, but also a novel intracellular site, raising questions about their interplay. Here, we performed all-atom molecular dynamics simulations of TAS2R14 in an explicit membrane to probe different receptor states: both cholesterol (extracellular) and aristolochic acid (intracellular) bound, only cholesterol bound, only aristolochic acid bound, and the apo receptor, with and without the G protein. Ligand occupancy at either site reshaped the volume, hydration, and conformational plasticity of both pockets and modulated the relative proximity of transmembrane helices 3 and 6. In simulations lacking the intracellular agonist but containing cholesterol, we observed intracellular entry of chloride ions and their long-lived interaction with the TAS2R-conserved R55 (BW position 2.50), revealing a charge-inverted interaction relative to the D2.50-sodium interaction described in many class A GPCRs. Apo simulations without G protein showed shorter-lived chloride visits to the same region. Together, these findings point to the intracellular pocket as a promising target for future mechanistic and ligand-design studies on bitter taste GPCRs.

  • Open Access

    Pharmaceutical TAS2R14 Agonists Display Diverse Potency, Efficacy, and Binding-Site Sensitivity

    by Shir Eyal, Nitsan Dallal, Alon Rainish, Evgenii Ziaikin, Einav Malach, Masha Y Niv

    Bitter taste receptors (TAS2Rs) are G- protein coupled receptors that detect chemically diverse compounds, including many clinically used drugs. TAS2R14 is expressed in many extraoral tissues and is activated by hundreds of ligands, including pharmaceutical drugs. Recent cryo-EM structures revealed a previously unrecognized intracellular binding pocket in TAS2R14, raising new questions regarding ligand binding modes. Here, we investigated the activation of TAS2R14 by Tamoxifen, Carbimazole, and Lidocaine using cell-based assays measuring proximal G-protein recruitment (BRET2) and downstream signaling (IP-One). Tamoxifen and Carbimazole activated TAS2R14 with EC50 values in the low micromolar range, whereas Lidocaine required substantially higher concentrations. Targeted receptor mutations were used to evaluate the contribution of extracellular and intracellular binding regions to agonist activity. Carbimazole and Lidocaine showed greater dependence on the intracellular and extracellular positions, respectively, while Tamoxifen displayed assay-dependent, but overall modest sensitivity to the tested mutations. Thus, although existing drugs can activate TAS2R14 through distinct binding modes, TAS2R14-directed repurposing will depend on whether effective local receptor concentrations can be achieved through appropriate delivery strategies.

  • Open Access

    Intracellular and dual-site inhibition of a bitter taste GPCR

    by Nitsan Dallal, Gil Daniel Paz, Noga Nir-Marom, Yael Keselman, Shir Eyal, Evgenii Ziaikin, Alon Rainish, Sam R.J. Hoare, Lior Peri, Einav Malach, et al.

    Bitter taste receptors (TAS2Rs) are G protein-coupled receptors expressed in both gustatory and extraoral tissues and activated by a broad range of compounds. TAS2R14 is among the most promiscuous members of this family, responding to many structurally diverse ligands. Cryo-electron microscopy structures of TAS2R14 have revealed agonists binding in an intracellular pocket, raising the question of the main sites of interaction for known TAS2R14 antagonists. To address this, we examined the effects of mutations at residues located in the extracellular and intracellular regions on receptor inhibition by three antagonist compounds: LF1, LF22 and probenecid. Mutations in the extracellular region reduced the inhibitory effect of LF22, whereas all three compounds showed reduced inhibition in the intracellular mutants. Computational co-folding of these ligands with TAS2R14 supported these observations, indicating that LF22 interacts with both top and bottom binding sites, whereas LF1 and probenecid engage predominantly the intracellular site adjacent to the G protein interface. Interestingly, LF1 is more potent for TAS2R16 than its known inhibitor probenecid. These findings reveal distinct inhibitory mechanisms among TAS2R antagonists and provide new insights into designing inhibitors of bitter taste.


  • Effects of the genetic polymorphisms of TAS2R43 and TAS2R46 on receptors’ function and on perceived bitterness of caffeine by human subjects

    by Rena Numabe, Alon Rainish, Masha Y Niv, Hiroo Imai

    We investigated the effects of coding single-nucleotide polymorphisms (SNPs) in bitter taste receptors TAS2R43 and TAS2R46 on their predicted structural stability, cellular functions, and human threshold for bitterness of caffeine. We found differences in the cell surface expression and reaction to caffeine among the haplotypes of TAS2R43 and -46 protein. Ancestral haplotypes of the proteins showed higher response to caffeine than derived haplotypes both for TAS2R43 and -46, which were also predicted to be less structurally stable and showed lower expression at the cell surface membrane. There was a significant difference in human bitter perception of caffeine between people with different TAS2R43 genotypes. Considering the functional differences based on their genotypes and the distribution of the haplotypes in the regions, these SNPs in TAS2R43 may relate to the sensitivity to several bitter compounds, which correlated with human evolution spread from Africa.